Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 25, Issue 2, 2000, Pages 167-172

  Leung, T F ^a,b   Chik, K W ^a   Li, C K ^a   Lai, H ^a   Shing, M M K ^a   Chan, P K S ^a   Lee, V ^a   Yuen, P M P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Haematopoietic stem cell transplantation; Herpes zoster; Paediatric; Varicella zoster virus

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; CHICKENPOX; CHILD; DISEASE DURATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; POSTHERPETIC NEURALGIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; VARICELLA ZOSTER VIRUS;

EID: 0033963169     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702119     Document Type: Article

References (27)

1. Feldman S, Hughes W, Daniel C. Varicella in children with cancer: 77 cases. Pediatrics 1975; 80: 388-397.
2. Kawasaki H, Takayama J, Ohira M. Herpes zoster infection after bone marrow transplantation in children. J Pediatr 1996; 128: 353-356.
3. Nakayama H, Okamura J, Ohga S et al. Herpes zoster in children with hone marrow transplantation: report from a single institution. Acta Paediatr Jpn 1995; 37: 302-307.
4. Sauerbrei A, Prager J, Hengst U et al. Varicella vaccination in children after bone marrow transplantation. Bone Marrow Transplant 1997; 20: 381-383.
5. Wacker P, Hartmann O, Benhamou E et al. Varicella-zoster virus infections after autologous bone marrow transplantation in children. Bone Marrow Transplant 1989; 4: 191-194.
6. Takaue Y, Okamoto Y, Kawano Y et al. Regeneration of immunity and varicella-zoster virus infection after high-dose chemotherapy and peripheral blood stem cell autografts in children. Bone Marrow Transplant 1994; 14: 219-223.
7. Schuchter LM, Wingard JR, Piantadosi S et al. Herpes zoster infection after autologous bone marrow transplantation. Blood 1989; 74: 1424-1427.
8. Shing MM, Yuen PM, Li CK et al. A more immunosuppressive pre-transplant conditioning may be required for Chinese patients with thalassaemia. Bone Marrow Transplant 1996; 17: 907-910.
9. Li CK, Yuen PM, Chik KW et al. Allogeneic peripheral blood stem cell transplant in children. Med Pediatr Oncol 1998; 30: 147-151.
10. Yuen PM, Chik KW, Li CK et al. Transplantation in childhood hematologic malignancies with closely matched family donors in Hong Kong. Transplant Proc 1998; 30: 3481-3483.
11. Han CS, Miller W, Haake R, Weisdorf D. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant 1994; 13: 277-283.
12. Gratama JW, Verdonck LF, van der Linden JA et al. Cellular immunity to vaccinations and herpesvirus infections after bone marrow transplantation. Transplantation 1986; 41: 719-724.
13. Novelli VM, Brunell PA, Geiser CF et al. Herpes zoster in children with acute lymphocytic leukaemia. Am J Dis Child 1988; 142: 71-72.
14. Wilson A, Sharp M, Koropchak CM et al. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation. J Infect Dis 1992; 165: 119-126.
15. Ljungman P, Lonnqvist B, Gahrton G et al. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients. J Inject Dis 1986; 153: 840-847.
16. Petursson G, Helgason S, Gudmundsson S, Sigurdsson JA. Herpes zoster in children and adolescents. Pediatr Infect Dis J 1998; 17: 905-908.
17. Locksley RM, Flournoy N, Sullivan KM, Meyers JD. Infection with varicella-zoster virus after marrow transplantation. J Infect Dis 1985; 152: 1172-1181.
18. Tzeng CH, Liu JH, Fan S et al. Varicella zoster virus infection after allogeneic or autologous hemopoietic stem cell transplantation. J Formos Med Assoc 1995; 94: 313-317.
19. Callum JL, Brandwein JM, Sutcliffe SB et al. Influence of total body irradiation on infections after autologous bone marrow transplantation. Bone Marrow Transplant 1991; 8: 245-251.
20. Meyers JD, Flournoy N, Thomas ED. Cell-mediated immunity to varicella-zoster virus after allogeneic marrow transplant. J Infect Dis 1980; 141: 479-487.
21. Sempere A, Sanz GF, Senent L et al. Long-term acyclovir prophylaxis for prevention of varicella zoster virus infection after autologous blood stem cell transplantation in patients with acute leukemia. Bone Marrow Transplant 1992; 10: 495-498.
22. Masaoka T, Hiraoka A, Teshima H, Tominaga N. Varicella-zoster virus infection in immunocompromised patients. J Med Virol 1993; (Suppl. 1): 82-84.
23. Reusser P, Cordonnier C, Einsele H et al. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1996; 17: 813-817.
24. LaRussa P, Steinberg S, Gershon AA. Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada. J Infect Dis 1996; 174 (Suppl. 3): S320-323.
25. Buda K, Tubergen DG, Levin MJ. The frequency and consequences of varicella exposure and varicella infection in children receiving maintenance therapy for acute lymphoblastic leukemia. J Pediatr Hematol Oncol 1996; 18: 106-112.
26. Redman RL, Nader S, Zerboni L et al. Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine. J Infect Dis 1997; 176: 578-585.
27. Lawrence R, Gershon AA, Holzman R, Steinberg SP, NIAID Varicella Vaccine Collaborative Study Group. The risk of zoster after varicella vaccination in children with leukemia. New Engl J Med 1988; 318: 543-548.